Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3635 Non-responders to Peptide Receptor Radionuclide Therapy (PRRT) – A single center retrospective analysis

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) has become the standard of care for patients (pts) with positive somatostatin receptor image, grade (G)1/2 gastrointestinal (GI) neuroendocrine tumors (NETs) after Somatostatin Analogues (SSAs) failure.

Conference:

Presenting Author: Laffi A

Authors: Laffi A, Rodari M, Lania A, Zerbi A, Elisabetta L,

Keywords: PRRT, neuroendocrine tumor, NET, Nuclear Medicine,

#3508 Liver transplantation for metastatic neuroendocrine tumors: Time to extend criteria?

Introduction: Liver transplant (LT) might be considered in patients with liver-only neuroendocrine metastases (NELM), but controversy continues surrounding patient selection.

Conference:

Presenting Author: Ross R

Authors: Rossi R, Maspero M, Coppa J, Sposito C, Bhoori S,

Keywords: neuroendocrine tumor, neuroendocrine liver metastasis, liver transplant,

#1861 Surgical Strategies and Selection Criteria for Patients with Liver Metastasis from Neuroendocrine Tumors: Personal Experience.

Introduction: The role of surgical treatment of liver metastasis from neuroendocrine neoplasm(NET) is still a debated issue,and the management of these patients is entrusted to the practical experience of single centers.The main problem is that there are not available randomized trials comparing surgical resection to unthreated patients or other liver directed therapy.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Pauletti B

Authors: Massani M, Pauletti B, Bonariol R, Bassi N,

Keywords: NET, liver metastasis, surgery,

#1396 3-Drugs Chemotherapy Regimen for G3 PanNENs with Ki67 below 55%: Single Institution Experience

Introduction: To date no standard regimen of chemotherapy (CTH) is universally approved for advanced pancreatic neuroendocrine neoplasms (PanNENs) with Ki67

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Grego E

Authors: Grego E, Cingarlini S, Ortolani S, Crosara S, De Robertis R,

Keywords: 3-drugs chemotherapy regimen, pancreatic nets, ki-67% <55%,

#620 Multicenter Retrospective Analysis of Systemic Chemotherapy for Advanced Poorly Differentiated Neuroendocrine Carcinoma of Digestive System

Introduction: No standard chemotherapy is established for advanced poorly differentiated neuroendocrine carcinoma (PDNEC) originating from the gastrointestinal tract (GI) or the hepato-biliary-pancreatic system (HBP).

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Tomohiro Y

Authors: Yamaguchi T, Machida N, Kasuga A, Takahashi H, Sudo K,

Keywords: poorly-differentiated, PDNEC, irinotecan, etoposide, gastrointestinal,